Anorexia - Epidemiology Forecast - 2032

Anorexia - Epidemiology Forecast - 2032

DelveInsight's ‘Anorexia Nervosa (AN)- Epidemiology Forecast–2032' report delivers an in-depth understanding of AN, historical and forecasted epidemiology as well as AN trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.

Anorexia Nervosa Disease Understanding

Anorexia nervosa (AN) is an eating disorder characterized by weight loss or lack of appropriate weight gain in growing children; difficulties maintaining an appropriate body weight for height, age, and stature; and, in many individuals, distorted body image. People with anorexia generally restrict the number of calories and the types of food they eat.

This disorder is characterized by deliberate weight loss, induced and sustained by the patient. It occurs most commonly in adolescent girls and young women, but adolescent boys and young men may also be affected, as many children approaching puberty and older women up to the menopause. The disorder is associated with specific psychopathology whereby a dread of fatness and flabbiness of body contour persists as an intrusive, overvalued idea, and the patients impose a low weight threshold on themselves. There is usually under nutrition of varying severity with secondary endocrine and metabolic changes and disturbances of bodily function.

Anorexia Nervosa Diagnosis

No objective test—such as bloodwork or an X-ray—can definitively point to an eating disorder. Instead, a doctor makes the diagnosis based on a person's symptoms. To diagnose anorexia, the doctor will ask about the person's symptoms, and they may also ask family members and other loved ones about their observations. If a doctor believes that a person has anorexia, they will attempt to diagnose the type. One type primarily involves restricting food intake, while another involves episodes of overeating and purging. If the person has experienced at least one of these episodes in the past 3 months, the doctor will likely diagnose binge eating and purging anorexia.

Diagnostic instruments in the form of questionnaires are used. Few of them are as follows:

Structured Inventory for Anorexic and Bulimic Eating Disorders Self-Report (SIAB-S)

Munich Eating and Feeding Disorder Questionnaire (Munich ED-Quest):

Eating Disorder Examination-Questionnaire for children (ChEDE-Q):

The SCOFF questionnaire

Continued in the report…..

Anorexia Nervosa Epidemiology Perspective by DelveInsight

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by total prevalent cases of anorexia nervosa, diagnosed prevalent cases of anorexia nervosa and gender-specific diagnosed prevalent cases of anorexia nervosa, scenario of Anorexia Nervosa in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom) and Japan from 2019 to 2032.

Anorexia Nervosa Detailed Epidemiology Segmentation

Total prevalent cases of anorexia nervosa in the 7MM were found to be approximately 1,692,817 in 2021. These cases are expected to increase by 2032 at a CAGR of 0.3% during the study period (2019–2032).

Among 7MM, the United States has the highest prevalent cases of anorexia nervosa with 703,497 cases in 2021.

The total diagnosed prevalent cases of anorexia nervosa in the 7MM were observed to be 812,552 in 2021. These cases are expected to increase during the study period (2019–2032).

Among the European countries, Germany had the highest diagnosed prevalent population of Anorexia nervosa with 86,928 cases, followed by the UK with 69,732 cases in 2021. On the other hand, Spain had the lowest diagnosed prevalent population.

In Japan, 128,408 diagnosed prevalent cases of anorexia nervosa were recorded in the year 2021.

As per DelveInsight's assessment, for anorexia nervosa, the gender-specific distribution of the disease suggests females at a higher count with 763,335 cases in the 7MM, in 2021.

Scope of the Report

The report covers the descriptive overview of anorexia nervosa, explaining its symptoms, grading, pathophysiology, and various diagnostic approaches.

The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

The report assesses the disease risk and burden of anorexia nervosa.

The report helps to recognize the growth opportunities in the 7MM concerning the patient population.

The report provides the segmentation of the disease epidemiology for 7MM, a total number of prevalent cases of anorexia nervosa, diagnosed prevalent cases of anorexia nervosa and gender-specific diagnosed prevalent cases of anorexia nervosa.

Report Highlights

11-Year Forecast of Anorexia nervosa

The 7MM Coverage

Total prevalent cases of anorexia nervosa

Diagnosed prevalent cases of anorexia nervosa

Gender-specific diagnosed prevalent cases of anorexia nervosa

Key Questions Answered

What are the disease risk and burdens of anorexia nervosa?

What is the historical anorexia nervosa patient pool in the United States, EU5 (Germany, France, Italy, Spain, and the UK), and Japan?

What would be the forecasted patient pool of anorexia nervosa at the 7MM level?

What will be the growth opportunities across the 7MM concerning the patient population about anorexia nervosa?

Out of the above-mentioned countries, which country would have the highest diagnosed prevalent population of anorexia nervosa during the forecast period (2022–2032)?

At what CAGR the population is expected to grow across the 7MM during the forecast period (2022–2032)?

Reasons to buy

The anorexia nervosa report will allow the user to -

Develop business strategies by understanding the trends shaping and driving the 7MM anorexia nervosa epidemiology forecast.

The anorexia nervosa epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists.

The anorexia nervosa epidemiology model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over the 11-year forecast period using reputable sources.

Key Assessments

Patient Segmentation

Disease Risk and Burden

Risk of disease by the segmentation

Factors driving growth in a specific patient population

Geographies Covered

The United States

EU5 (Germany, France, Italy, Spain, and the United Kingdom)

Japan

Study Period: 2019–2032